Your browser doesn't support javascript.
loading
Facile and Unplugged Surface Plasmon Resonance Biosensor with NIR-Emitting Perovskite Nanocomposites for Fast Detection of SARS-CoV-2.
Chen, Lung-Chien; Li, Meng-Chi; Chen, Kai-Ren; Cheng, Yu-Jui; Wu, Xun-Ying; Chen, Sih-An; Youh, Meng-Jey; Kuo, Chien-Cheng; Lin, Yu-Xen; Lin, Chih-Yen; Wang, Chu-Feng; Huang, Chung-Feng; Lin, Shang-Yi; Wang, Wen-Hung; Chen, Yen-Hsu; Yu, Ming-Lung; Thitithanyanont, Arunee; Wang, Sheng-Fan; Su, Li-Chen.
  • Chen LC; Department of Electro-Optical Engineering, National Taipei University of Technology, Taipei 10608, Taiwan.
  • Li MC; Thin Film Technology Center, National Central University, Taoyuan 32001, Taiwan.
  • Chen KR; Optical Sciences Center, National Central University, Taoyuan 32001, Taiwan.
  • Cheng YJ; Department of Optics and Photonics, National Central University, Taoyuan 32001, Taiwan.
  • Wu XY; Department of Electronic Engineering, Ming Chi University of Technology, New Taipei City 24301, Taiwan.
  • Chen SA; Department of Mechanical Engineering, Ming Chi University of Technology, New Taipei City 24301, Taiwan.
  • Youh MJ; Department of Electro-Optical Engineering, National Taipei University of Technology, Taipei 10608, Taiwan.
  • Kuo CC; Department of Mechanical Engineering, Ming Chi University of Technology, New Taipei City 24301, Taiwan.
  • Lin YX; Thin Film Technology Center, National Central University, Taoyuan 32001, Taiwan.
  • Lin CY; Department of Optics and Photonics, National Central University, Taoyuan 32001, Taiwan.
  • Wang CF; TeraOptics Corporation, Taoyuan 32472, Taiwan.
  • Huang CF; Center for Tropical Medicine and Infectious Disease Research, Kaohsiung Medical University, Kaohsiung 80708, Taiwan.
  • Lin SY; Department of Medical Laboratory Science and Biotechnology, Kaohsiung Medical University, Kaohsiung 80708, Taiwan.
  • Wang WH; Clinical Microbiology Laboratory, Department of Laboratory Medicine, Kaohsiung Medical University Hospital, Kaohsiung Medical University, Kaohsiung 80708, Taiwan.
  • Chen YH; Hepatobiliary Division, Department of Internal Medicine, Kaohsiung Medical University Hospital, Kaohsiung Medical University, Kaohsiung 80708, Taiwan.
  • Yu ML; Ph.D. Program in Translational Medicine, College of Medicine, Kaohsiung Medical University, Kaohsiung, and Academia Sinica, Kaohsiung 80708, Taiwan.
  • Thitithanyanont A; Faculty of Internal Medicine and Hepatitis Research Center, College of Medicine, and Center for Cohort Study, Kaohsiung Medical University, Kaohsiung 80708, Taiwan.
  • Wang SF; Clinical Microbiology Laboratory, Department of Laboratory Medicine, Kaohsiung Medical University Hospital, Kaohsiung Medical University, Kaohsiung 80708, Taiwan.
  • Su LC; Division of Infectious Disease, Department of Internal Medicine, Kaohsiung Medical University Hospital, Kaohsiung Medical University, Kaohsiung 80708, Taiwan.
Anal Chem ; 95(18): 7186-7194, 2023 05 09.
Article en En | MEDLINE | ID: mdl-37103881
ABSTRACT
The emergence of the coronavirus disease 2019 (COVID-19) pandemic prompted researchers to develop portable biosensing platforms, anticipating to detect the analyte in a label-free, direct, and simple manner, for deploying on site to prevent the spread of the infectious disease. Herein, we developed a facile wavelength-based SPR sensor built with the aid of a 3D printing technology and synthesized air-stable NIR-emitting perovskite nanocomposites as the light source. The simple synthesis processes for the perovskite quantum dots enabled low-cost and large-area production and good emission stability. The integration of the two technologies enabled the proposed SPR sensor to exhibit the characteristics of lightweight, compactness, and being without a plug, just fitting the requirements of on-site detection. Experimentally, the detection limit of the proposed NIR SPR biosensor for refractive index change reached the 10-6 RIU level, comparable with that of state-of-the-art portable SPR sensors. In addition, the bio-applicability of the platform was validated by incorporating a homemade high-affinity polyclonal antibody toward the SARS-CoV-2 spike protein. The results demonstrated that the proposed system was capable of discriminating between clinical swab samples collected from COVID-19 patients and healthy subjects because the used polyclonal antibody exhibited high specificity against SARS-CoV-2. Most importantly, the whole measurement process not only took less than 15 min but also needed no complex procedures or multiple reagents. We believe that the findings disclosed in this work can open an avenue in the field of on-site detection for highly pathogenic viruses.
Asunto(s)

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Técnicas Biosensibles / Nanocompuestos / COVID-19 Tipo de estudio: Diagnostic_studies Límite: Humans Idioma: En Año: 2023 Tipo del documento: Article

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Técnicas Biosensibles / Nanocompuestos / COVID-19 Tipo de estudio: Diagnostic_studies Límite: Humans Idioma: En Año: 2023 Tipo del documento: Article